| Tue, 18 Feb 2020 16:51:46: | BMS leans on new long-term Opdivo data in crowded kidney cancer field
|
| Tue, 18 Feb 2020 16:08:24: | GlaxoSmithKline, Alcon switch 3 meds to OTC in play for big volume
|
| Tue, 18 Feb 2020 15:33:54: | Sanofi, despite Zika controversy, jumps into HHS coronavirus vaccine partnership
|
| Tue, 18 Feb 2020 15:18:20: | Dr. Reddy's sterile plant now meets at least minimal compliance, FDA says
|
| Tue, 18 Feb 2020 14:12:17: | Former Novartis exec pleads guilty in generics price-fixing conspiracy
|
| Mon, 17 Feb 2020 15:35:02: | FDA anticipates disruptions, shortages as China outbreak plays out
|
| Fri, 14 Feb 2020 15:54:49: | New Astellas, Seattle Genetics Padcev combo data spark $5.8B sales hopes
|
| Fri, 14 Feb 2020 15:39:17: | Concern for drug shortages grows as COVID-19 outbreak drags on
|
| Fri, 14 Feb 2020 15:36:47: | FiercePharmaAsia—Gilead remdesivir's copy; Enhertu's early launch; Tecentriq's China nod
|
| Fri, 14 Feb 2020 04:11:03: | Eisai will pull obesity drug Belviq off U.S. shelves after FDA flags cancer risks
|
| Fri, 14 Feb 2020 02:24:48: | Sun tackles stigma around teen acne 'eruptions' with online awareness campaign
|
| Thu, 13 Feb 2020 16:41:19: | GBT takes a page from HIV playbook as it embarks on Oxbryta launch
|
| Thu, 13 Feb 2020 15:49:37: | How will coronavirus hit U.S. drugmakers? Depends what kind of drugmaker you are: Moody's
|
| Thu, 13 Feb 2020 15:03:50: | Can Jakafi hit $3B? Incyte thinks so—and it's got other launches on the way
|
| Thu, 13 Feb 2020 13:56:39: | 400 Novartis workers prepare for job losses at U.K. manufacturing site
|
| Thu, 13 Feb 2020 13:22:22: | Picture this: Bayer artist paints heart attack survivors into living murals to highlight hidden risks
|
| Wed, 12 Feb 2020 16:37:32: | NICE rejects Merck's Keytruda kidney cancer combo, keeping pressure off BMS
|
| Wed, 12 Feb 2020 16:01:12: | Merck's Keytruda rides breast cancer hot streak to frontline chemo-combo win
|
| Wed, 12 Feb 2020 15:28:05: | Wockhardt selling plant and piece of its business to Dr. Reddy's for $260M
|
| Wed, 12 Feb 2020 14:53:16: | Sanofi CEO Hudson singles out his digital ambitions in big executive shakeup
|
| Wed, 12 Feb 2020 14:21:35: | Chinese firm copies Gilead's remdesivir, the most promising drug against the new coronavirus
|
| Tue, 11 Feb 2020 15:37:19: | Akorn and lenders negotiate its future again
|
| Tue, 11 Feb 2020 15:25:29: | Pfizer, Astellas' Xtandi scores Bayer-matching win in extending prostate cancer patients' lives
|
| Tue, 11 Feb 2020 14:46:11: | Trump's budget proposes moderate pricing reforms, but executive action in Part B could follow: Bloomberg
|
| Tue, 11 Feb 2020 14:39:07: | FDA eases hold as Marker Therapeutics T-cell manufacturing issues addressed
|
